Page 2 - Program For Appropriate Technology In Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Program for appropriate technology in health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Program For Appropriate Technology In Health Today - Breaking & Trending Today

World Heart Day: AstraZeneca intensifies commitment to tackle CVD across Africa World

Multinational pharmaceutical and biotechnology company, AstraZeneca, has reassured its commitment to tackling cardiovascular diseases (CVDs), across the African continent through the Healthy Heart Africa (HHA) programme. ....

Deepak Arora , Yvette Kisaka , Robert Yeboah , Program For Appropriate Technology In Health , World Health Day , World Health Organisation , Ghana Health Service , Healthy Heart Africa , Country President , Africa Cluster , Heart Africa , World Heart Day , Know Heart , Technical Advisor , Non Communicable Diseases , Appropriate Technology , Health Minister , Heart Day , Member States ,

The US quietly terminates a controversial $125m wildlife virus hunting programme amid safety fears

Two years after launching what officials hailed as a five year flagship project for hunting viruses among wildlife to prevent human pandemics, the US Agency for International Development is shuttering the enterprise. David Willman reports

A flagship project for the controversial practice of hunting viruses among wildlife in South East Asia, Africa, and Latin America to prevent human outbreaks and pandemics is being quietly dropped by the United States Agency for International Development (USAID) after private and bipartisan criticism over the safety of such research, The BMJ has found.

For more than a decade the US government has been funding international projects engaged in identifying exotic wildlife viruses that might someday infect humans. Although critics have raised concerns over the potentially catastrophic risks of such virus hunting activities,1 hundreds of millions of dollars in unabated funding have symbolised a commitment to the effort.

The shuttering ....

United States , New York , Krung Thep Mahanakhon , Washington State University , White House , District Of Columbia , North Carolina , University Of Washington , South Carolina , Erics Lander , Daniel Gastfriend , Michael Dickens , Edward Holmes , Kevin Esvelt , David Willman , Peter Daszak , James Risch , Andrew Rambaut , Samantha Power , Lawrence Tabak , Atul Gawande , Thiravat Hemachudha , Tom Daschle , Lindsey Graham , Jason Matheny , Karen Howard ,

Meningococcal NmCV-5 Vaccine is effective in 2-to-29-year-olds in Mali and Gambia

Bookmark 1. In this randomized controlled trial, the NmCV-5 vaccine elicited an immune response that was noninferior to the MenACWY-D vaccine in two-to-29-year-olds in Mali and Gambia. 2. The NmCV-5 vaccine had a similar incidence of adverse events as compared to the MenACWY-D vaccine. Evidence Rating Level: 1 (Excellent) Study Rundown: The highest incidence of ....

Program For Appropriate Technology In Health , Minute Medicine Inc , Serum Institute Of India , World Health Organization , Rating Level , Serum Institute , Appropriate Technology , Global Control , Confidence Interval ,

Meningococcal NmCV-5 Vaccine is effective in 2-to-29-year-olds in Mali and Gambia

1. In this randomized controlled trial, the NmCV-5 vaccine elicited an immune response that was noninferior to the MenACWY-D vaccine in two-to-29-year-olds in Mali and Gambia. 2. The NmCV-5 vaccine had a similar incidence of adverse events as compared to the MenACWY-D vaccine. Evidence Rating Level: 1 (Excellent) Study Rundown: The highest incidence of meningitis ....

Minute Medicine Inc , World Health Organization , Serum Institute Of India , Program For Appropriate Technology In Health , Rating Level , Serum Institute , Appropriate Technology , Global Control , Confidence Interval , Infectious Disease , Menacwy D , Meningococcal Nmcv 5 Vaccine , Meningococcal Vaccine , Public Health ,

NmCV-5 vaccine safety and immunogenicity against bacterial meningitis in Mali and Gambia

Researchers evaluated the safety and non-inferiority of the pentavalent meningococcal NmCV-5 vaccine. ....

Serum Institute Of India , World Health Organization , World Health Assembly , Program For Appropriate Technology In Health , New England Journal , Image Credit , Defeating Meningitis , Appropriate Technology , Serum Institute ,